Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Sigma, a leader in AI applications for business, today announced preliminary business results for the fiscal year ending January 31, 2026, highlighting record momentum in revenue and customer adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results